Burger King wants customers to indulge in its new Guilty Butter Croquette Sandwich, saying cheat days should be thoroughly enjoyed by going all out in high-calorie style with extra butter.
The fast-food giant is sure that this new Guilty “Butter Coro” Sandwich, as they’re affectionately calling it, would captivate its clients.
It’s a bold move by Burger King to choose the start of the year to release a new guilty pleasure when most are likely planning to stick to a better diet.
For those who have broken their New Year’s resolutions, they can indulge with butter-soaked buns and a “newly developed special butter croquette” along with its creamy mayonnaise and a special cheese sauce.
But there are pickles, onions, and lettuce to provide some nutrition and refreshment.
The burger, priced at 640 yen (US$5.52), made its debut at select locations around January 7.
Back in October, the fast-food giant offered the Guilty Butter Beef Burger and Guilty Butter Chicken Burger, which both feature its new “craft buns” that have been soaked in butter.
Customers couldn’t resist these guilty pleasures back then.


Gold Prices Hover Near Three-Month High as Oil, Treasury Yields Fall
Tesla Raises Cybertruck Prices by $5,000 in US
BOJ’s Himino Signals Timely Rate Hikes as Inflation Risks Rise
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
OpenAI AI Agent Swarm Behind Hugging Face Hack
Trump Buys SpaceX Shares After Record IPO
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Why a ‘rip-off’ degree might be worth the money after all – research study
US Stocks Finish Flat as Inflation Data, Nvidia Earnings Keep Investors Cautious
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
Asian Stocks Slip Ahead of Nvidia Earnings and US Inflation Data
What’s the difference between baking powder and baking soda? It’s subtle, but significant
6 simple questions to tell if a ‘finfluencer’ is more flash than cash
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 



